Rankings
▼
Calendar
PRTA Q4 2024 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena
PRTA
Prothena Corporation plc
$549M
Q4 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
+571.8% YoY
Gross Profit
$2M
100.0% margin
Operating Income
-$65M
-3056.9% margin
Net Income
-$58M
-2729.9% margin
EPS (Diluted)
$-1.08
QoQ Revenue Growth
+118.9%
Cash Flow
Operating Cash Flow
-$48M
Free Cash Flow
-$48M
Stock-Based Comp.
$11M
Balance Sheet
Total Assets
$547M
Total Liabilities
$60M
Stockholders' Equity
$487M
Cash & Equivalents
$471M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$316,000
+571.8%
Gross Profit
$2M
-$62M
+103.4%
Operating Income
-$65M
-$79M
+17.3%
Net Income
-$58M
-$67M
+14.1%
Revenue Segments
Collaboration
$134M
100%
← FY 2024
All Quarters
Q1 2025 →